Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al-Reference-Cited by-同舟云学术

Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al

Published:2021-11-01 Issue: Volume: Page:annrheumdis-2021-221423
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Kiltz Uta^ORCID,Braun Juergen^ORCID

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Molto A , López-Medina C , Van den Bosch FE . Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial. Ann Rheum Dis 2021.doi:10.1136/annrheumdis-2020-219585

2. ASAS Health Index: The “All in One” for Spondyloarthritis Evaluation?

3. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS

4. Braun J , Baraliakos X , Kiltz U . Nature Rev Rheum 2021 Nat Rev Rheumatol 2021 Sep;17(9):565-576. online ahead of print July 26th..

5. ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axial spondyloarthritis—current aspects;Exploration of Musculoskeletal Diseases;2024-07-24

2. Go or no-go for treat-to-target in axial spondyloarthritis?;Current Opinion in Rheumatology;2023-04-25